Targeting Drug-Sensitive and -Resistant Strains of Mycobacterium tuberculosis by Inhibition of Src Family Kinases Lowers Disease Burden and Pathology

In view of emerging drug resistance among bacterial pathogens, including Mycobacterium tuberculosis, the development of novel therapeutic strategies is increasingly being sought. A recent paradigm in antituberculosis (anti-TB) drug development is to target the host molecules that are crucial for int...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandra, Pallavi, Rajmani, R. S., Verma, Garima, Bhavesh, Neel Sarovar, Kumar, Dhiraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894694/
https://www.ncbi.nlm.nih.gov/pubmed/27303736
http://dx.doi.org/10.1128/mSphere.00043-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894694/
https://www.ncbi.nlm.nih.gov/pubmed/27303736
http://dx.doi.org/10.1128/mSphere.00043-15

Ejemplares similares